Inicio › Cáncer de pulmón de células no pequeñas › Florida › Deltona
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Deltona, FL
15 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Deltona y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
ReclutandoFase 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · A 4 mi de distancia
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
ReclutandoFase 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · A 4 mi de distancia
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Alpha Clinical Research Centers LLC, Orange City · A 4 mi de distancia
- Florida Cancer Specialists, Orange City · A 4 mi de distancia
- Mid Florida Hematology and Oncology Center, Orange City · A 4 mi de distancia
- y 1 más
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ReclutandoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · A 4 mi de distancia
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
ReclutandoFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · A 4 mi de distancia
Pan-tumor MRD Study
ReclutandoEstudio observacional
- Mid Florida Cancer Centers, Orange City · A 4 mi de distancia
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
ReclutandoFase 3
- Research Site, Orange City · A 4 mi de distancia
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
ReclutandoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · A 4 mi de distancia
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ReclutandoFase 2/3
- Mid Florida Cancer Centers, Orange City · A 4 mi de distancia
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
ReclutandoFase 3
- Mid Florida Hematology and Oncology Center, Orange City · A 4 mi de distancia
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ReclutandoFase 2/3
- Local Institution - 007-926-B, Daytona Beach · A 26 mi de distancia
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
ReclutandoFase 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · A 4 mi de distancia
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
ReclutandoFase 3
- Research Site, Orange City · A 4 mi de distancia
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
ReclutandoFase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · A 4 mi de distancia
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
ReclutandoFase 2
- Mid Florida Hematology and Oncology Center, Orange City · A 4 mi de distancia
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Deltona
- Obesidad11 estudios
- Enfermedad de Alzheimer10 estudios
- Diabetes tipo 210 estudios
- Sobrepeso9 estudios
- Cáncer de seno8 estudios
- Cáncer de pulmón8 estudios
- Cáncer (todos los tipos)7 estudios
- Cáncer metastásico5 estudios
- Enfermedad de obstrucción pulmonar crónica5 estudios
- Presión arterial alta5 estudios
- Melanoma5 estudios
- Osteoartritis de rodilla5 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.